Trials / Completed
CompletedNCT00699946
Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery
A Double-Blind, Randomized, Placebo-Controlled Study of Perioperative Administration of Olanzapine to Prevent Postoperative Delirium in Joint Replacement Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 495 (actual)
- Sponsor
- The New England Baptist Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
In this study we wanted to determine if perioperative administration of olanzapine prior to knee or hip replacement surgery in high risk patients would prevent the onset of postoperative delirium.
Detailed description
Postoperative delirium is a serious and common (20% to 60%) complication in orthopedic surgery patients. In this study we investigate whether prophylactic administration of olanzapine can prevent delirium from occurring after knee or hip replacement in high-risk patients \> 65 years of age. This is a randomized, double-blind, single center, placebo-controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olanzapine | 5 mg preoperative and 5mg postoperative prior to discharge to inpatient nursing floor |
| DRUG | placebo | placebo administered preoperatively and postoperatively prior to discharge to inpatient nursing floor |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-08-01
- Completion
- 2007-10-01
- First posted
- 2008-06-18
- Last updated
- 2009-01-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00699946. Inclusion in this directory is not an endorsement.